<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04764266</url>
  </required_header>
  <id_info>
    <org_study_id>Glycocalyx during NMP</org_study_id>
    <nct_id>NCT04764266</nct_id>
  </id_info>
  <brief_title>Glycocalyx During Normothermic Machine Perfusion</brief_title>
  <official_title>Glycocalyx Damage During Normothermic Graft Perfusion in Orthotopic Liver Transplantation - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An organ intended for transplantation is normally stored on ice (cold storage, CS) after&#xD;
      explantation from the donor. During this storage process, damage to the endothelial&#xD;
      glycocalyx occurs. It is known from numerous studies that the integrity of the endothelial&#xD;
      glycocalyx is necessary for organ function. Normothermic machine perfusion is an alternative&#xD;
      storage method for explanted livers, where the graft is perfused with warm blood. This study&#xD;
      aims to clarify the influence of normothermic machine perfusion on endothelial glycocalyx&#xD;
      damage of the graft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Syndecan 1 level during normothermic machine perfusion</measure>
    <time_frame>24 hours</time_frame>
    <description>Syndecan 1 level at the end of normothermic perfusion compared to the beginning of perfusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heparansulfate level during normothermic machine perfusion</measure>
    <time_frame>24 hours</time_frame>
    <description>Heparansulfate level at the end of normothermic perfusion compared to the beginning of perfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Syndecan 1 after transplantation</measure>
    <time_frame>72 hours</time_frame>
    <description>Change of Syndecan 1 level after transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heparansulfate level after transplantation</measure>
    <time_frame>72 hours</time_frame>
    <description>Change of Syndecan 1 level after transplantation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glycocalyx</condition>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Normothermic Machine Perfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood sampling at 5 time points after transplantation Perfusate collection at 3 time points during normothermic machine perfusion prior to transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Heparansulfate and Syndecan 1</intervention_name>
    <description>Blood samples will be collected from the patient at 5 different time points. Three perfusate samples will be collected during normothermic machine perfusion (4,9ml each).</description>
    <arm_group_label>Normothermic Machine Perfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First deceased donor liver transplantation receiving a graft after normothermic&#xD;
             machine perfusion&#xD;
&#xD;
          -  Recipient age &gt;18 years&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Mathis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Innsbruck</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon Mathis, MD</last_name>
    <phone>004350482139</phone>
    <email>simon.mathis@i-med.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University Innsbruck, Department of Anesthesia and Intensive Care Medicine</name>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Mathis, MD</last_name>
      <phone>004350482139</phone>
      <email>simon.mathis@i-med.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

